Senior Scientist, Antibody Engineering & Developability

argenx SE; Oost-Vlaanderen; Sur place; EUR 68 000 - 94 000; Plein temps

Avantages offerts par ce poste

Competitive salary

Incentives program

On-site Ghent

Résumé du poste

argenx in Ghent, Belgium is seeking a (Senior) Scientist to advance early development of therapeutic antibodies. The role focuses on antibody production, purification, analytical characterization, developability assessment, and sequence optimization, with hands-on protein work and cross‑functional collaboration.

You will coordinate late preclinical/early CMC activities from construct design through expression, purification, QC and developability evaluation, guiding molecule‑selection decisions

Qualifications

• Ph.D. in Biochemistry, Molecular Biology or related field with antibody biology expertise.
• Experience with recombinant protein production and purification.
• Knowledge of developability risks (aggregation, viscosity, stability).
• Strong project-management and cross-team collaboration.

Responsabilités

• Coordinate late preclinical/early CMC activities from construct design to developability evaluation.
• Collaborate with antibody engineering, analytical, computational and project teams.
• Provide scientific leadership, mentoring and external collaboration.
• Translate complex data into clear recommendations for molecule selection.

Connaissances

Antibody biology

Analytical & problem-solving

Excellent communication

English proficiency

Project management

Formation

Ph.D. in Biochemistry or Molecular Biology

Outils

Protein purification

Developability assessment

Sequence optimization

QC & analytics

Description du poste

argenx in Ghent, Belgium is seeking a (Senior) Scientist to advance early development of therapeutic antibodies. The role focuses on antibody production, purification, analytical characterization, developability assessment, and sequence optimization, with hands-on protein work and cross‑functional collaboration.

You will coordinate late preclinical/early CMC activities from construct design through expression, purification, QC and developability evaluation, guiding molecule‑selection decisions